$ACT Recent News 10 S&P 500 companies with the fastest

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 10:00 AM

$ACT Recent News

10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Today - Philip van Doorn
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Actavis sales surge, exceed forecasts 7:51 a.m. Nov. 5, 2014 - MarketWatch.com
Media, consumer-based company earnings to test stock rally 4:30 a.m. Nov. 2, 2014 - Wallace Witkowski
Pfizer sales fall less than expected 7:34 a.m. Oct. 28, 2014 - MarketWatch.com
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
In focus: Volatility ramps up 5:35 p.m. Oct. 8, 2014 - Lawrence G. McMillan
Small-cap buckling and trap doors could make for a brutal earnings season 6:07 a.m. Oct. 8, 2014 - Shawn Langlois
Valeant to boost Allergan bid by $15 a share: report 5:48 p.m. Oct. 7, 2014 - Russ Britt
Actavis agrees to acquire Durata Therapeutics 8:44 a.m. Oct. 6, 2014 - Tess Stynes
Pharma love triangle is a win, win, win for investors 1:11 p.m. Oct. 2, 2014 - The Trading Deck
In focus: Finally, a breakdown 7:40 p.m. Oct. 1, 2014 - Lawrence G. McMillan
In focus: Back in the trading range 2:26 p.m. Sept. 24, 2014 - Lawrence G. McMillan
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Actavis's Salix play undermines Allergan defense 11:43 a.m. Sept. 24, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:42 a.m. Sept. 24, 2014 - Russ Britt
Actavis shares rise on report of Pfizer approach 2:49 p.m. Sept. 23, 2014 - Ciara Linnane
Botox maker Allergan rejected Actavis takeover bid 6:18 p.m. Sept. 22, 2014 - Jonathan D. Rockoff
In focus: Market giving mixed signals 7:02 p.m. Sept. 17, 2014 - Lawrence G. McMillan
DEA restricts narcotic pain-drug prescriptions 7:27 p.m. Aug. 21, 2014 - Louise Radnofsky

Actavis Says 'Let's Make A Deal' 17 min ago - Seeking Alpha
Actavis (ACT) Upgraded From Hold to Buy 54 min ago - TheStreet.com
A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio 5:16 p.m. Nov. 9, 2014 - GuruFocus.com
Ackman Calls for Auction of Allergan 3:38 p.m. Nov. 7, 2014 - The Wall Street Journal Interactive Edition
3 Stocks Dragging In The Drugs Industry 12:06 p.m. Nov. 7, 2014 - TheStreet.com
Comparing America's 3 Largest Generic Drugs Companies 10:05 a.m. Nov. 7, 2014 - Seeking Alpha
Salix Shares Plunge on Accounting Revision 8:57 p.m. Nov. 6, 2014 - The Wall Street Journal Interactive Edition
Ironwood Pharmaceuticals' Q3 Loss Narrower than Expected - Analyst Blog 1:20 p.m. Nov. 6, 2014 - Zacks.com
Company News for November 06, 2014 - Corporate Summary 10:10 a.m. Nov. 6, 2014 - Zacks.com
How Billionaires Stack Up in Bill Ackman's Big Allergan Bid 9:25 a.m. Nov. 6, 2014 - TheStreet.com
Deutsche Bank’s U.S. Stock Selection Best Buy Ideas 7:43 a.m. Nov. 6, 2014 - 247WallSt.com
Jim Cramer's Top Stock Picks: LMT MPC ACT 6:00 a.m. Nov. 6, 2014 - TheStreet.com
Cramer's Mad Money - Actavis, What A Stock (11/5/14) 5:57 a.m. Nov. 6, 2014 - Seeking Alpha
2 Biotech Stocks to Buy After Earnings 5:45 a.m. Nov. 6, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks 8:20 p.m. Nov. 5, 2014 - TheStreet.com
10-Q: ACTAVIS PLC 5:06 p.m. Nov. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Actavis (ACT) Earnings Report: Q3 2014 Conference Call Transcript 2:10 p.m. Nov. 5, 2014 - TheStreet.com
3 IBD 50 Tech, Drug Stocks With Earnings Thursday 1:49 p.m. Nov. 5, 2014 - Investors Business Daily
Actavis' (ACT) CEO Brent Saunders on Q3 2014 Results - Earnings Call Transcript 1:29 p.m. Nov. 5, 2014 - Seeking Alpha
Actavis Beats Q3 Estimates As Buyout Talk Swirls 10:07 a.m. Nov. 5, 2014 - Investors Business Daily

Actavis Names Maria Teresa Hilado Chief Financial Officer 4:15 p.m. Nov. 10, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Actavis Announces Planned Retirement of R. Todd Joyce in Early 2015 6:45 a.m. Nov. 5, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 83% to $3.7 Billion in Third Quarter 2014; Non-GAAP EPS Increases 53% to $3.19 6:30 a.m. Nov. 5, 2014 - PR Newswire - PRF
Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata 4:15 p.m. Oct. 31, 2014 - PR Newswire - PRF
Actavis Confirms Appeals Court Upholds Lo Loestrin® Fe Patent 8:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
New Medicare Plan, Clinical Study Results, ANDA Filing Confirmation, Strategic Collaboration, and Merger Termination - Research Reports on UnitedHealth, Celgene, Actavis, Bristol-Myers Squibb and Salix 9:10 a.m. Oct. 22, 2014 - PR Newswire - PRF
Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 8:30 a.m. Oct. 22, 2014 - PR Newswire - PRF
Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 8:30 a.m. Oct. 22, 2014 - PR Newswire - PRF
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt 8:40 a.m. Oct. 20, 2014 - PR Newswire - PRF
Actavis Confirms Generic Quillivant XR® Patent Challenge 8:00 a.m. Oct. 16, 2014 - PR Newswire - PRF
Acquisition, Market Activity, and Upcoming Events - Research Reports on Auxilium, Lakeland, Endo, Actavis and Celgene 8:30 a.m. Oct. 14, 2014 - PR Newswire - PRF
Ironwood and Actavis to Present Linaclotide Data at the American College of Gastroenterology 2014 Annual Scientific Meeting 8:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
EQUITY ALERT: Rosen Law Firm Announces Investigation of Durata Therapeutics, Inc. Concerning its Proposed Sale to Actavis plc – DRTX 11:35 a.m. Oct. 6, 2014 - BusinessWire - BZX
DURATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 11:34 a.m. Oct. 6, 2014 - PR Newswire - PRF
Actavis to Acquire Durata Therapeutics, Inc. 8:00 a.m. Oct. 6, 2014 - PR Newswire - PRF
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 9:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Supernus Sues Actavis for Infringement of Trokendi XR(R) Patents 7:30 a.m. Oct. 2, 2014 - GlobeNewswire
Actavis to Host Third Quarter 2014 Earnings Conference Call and Webcast 8:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Actavis Confirms Generic Butrans® Patent Challenge 4:05 p.m. Sept. 25, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insilico Joins HKEX Tech 100: AI and Pharma Synergies

Insilico Medicine just locked down a spot in the HKEX Tech 100 Index, and that's a pretty big deal, if you ask me. This Cambridge-based outfit is making waves with its generative AI wizardry in drug discovery. It's not just about earning a tech badge of honor here; it's about opening doors to new investors and bolstering liquidity. When changes hit on September 14, 2026,...

Aurzen's ZIP Pro: A Mobile Cinema Revolution?

Aurzen ZIP Pro: A Big Splash in Times Square In the bustling heart of Manhattan, the glitz and glam of Times Square will shine a bit brighter this Fall. Why? Because Aurzen's introducing their latest gadget, the ZIP Pro. It’s a tri-fold Full HD pocket projector that, frankly, is aiming to redefine portable viewing. Boasting the ability to unfurl an 80-inch...

Ace Hardware Hits 100th Store Milestone, Talks Growth

Ace Hardware Signals Expansion Through 100th Store Anyone eying the hardware retail landscape knows that Ace Hardware is not just coasting through another predictable quarter. No, this coop, fondly dubbed the helpful hardware folks, has just cranked open the doors on its 100th new store of 2026. Yep, they're charging full-throttle on their expansion strategy, determined...

Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

Texas Institute Leads Trailblazing Arrhythmia Study

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

K-Royal Culture Festival 2026: A Global Heritage Experience

The K-Royal Culture Festival is rolling out in Fall 2026 with a flair that promises to capture the globetrotters' imaginations and then some. South Korea's signature national heritage jamboree is popping off from October 7 through October 11, 2026, at four magnificent palaces and the Jongmyo Shrine. If you're into discovering the depths of a place's history through...

Veteran Suicide Prevention: The Urgency Behind CVN's Push

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Viventium's New Healthcare Platform: A Game Changer

Revolution in Workforce Management for Healthcare When a healthcare company like Viventium decides to expand its human capital management (HCM) platform, you've got to sit up and take notice, especially in a field that's been biting its nails over workforce headaches for years. Staffing shortages, growing compliance hurdles, and labor costs squeezing tighter than...

Tahoe Truckee Life TV Series Elevates Local Flavor

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...